1. 제1저자 및 주요저자

Long-Term Outcome of a Multicenter Prospective Study on Efficacy and Safety of High-Dose Stereotactic Body Radiation Therapy ≥48-h Interfraction Interval for ≤5 cm Hepatocellular Carcinoma. Jin-Kyu Kang et al. Liver Cancer. 2024. e-pub

Clinical Utilization and Infrastructure of Radiation Therapy in Korea in 2020 and 2021.Jin-Kyu Kang et al. Anticancer Res. 2025 Apr;45(4):1761-1775.

Chromosome aberration dynamics in breast cancer patients treated with radiotherapy: Implications for radiation biodosimetry. JK Kang et al. Mutat Res Genet Toxicol Environ Mutagen. 2021 Oct;872:503419

UNSCEAR 2019 REPORT. Sources, effects and risks of ionizing radiation.

Health Effects of Radon Exposure. Kang JK, Seo SW, Jin YW. Yonsei Med J. 2019 Jul;60(7):597-603 

UNSCEAR 2017 REPORT. Sources, effects and risks of ionizing radiation.

The clinical utilization of radiation therapy in Korea between 2009 and 2013. Kang JK, Kim MS, Jang WI et al. Radiat Oncol J. 2016 Jun;34(2):88-95

The Clinical Status of Radiation Therapy in Korea in 2009 and 2013. Kang JK, Kim MS, Jang WI et al. Cancer Res Treat. 2016 Jul;48(3):892-8

Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization. Kang JK, Kim MS, Cho CK et al. Cancer. 2012 Nov 1;118(21):5424-31

Image-guided stereotactic body radiation therapy for localized prostate cancer. Kang JK, Cho CK, Choi CW et al. Tumori. 2011 Jan-Feb;97(1):43-8

Oligometastases confined one organ from colorectal cancer treated by SBRT. Kang JK, Kim MS, Kim JH et al. Clin Exp Metastasis. 2010 Apr;27(4):273-8

The Usefulness of 18F-FDG PET/CT for Predicting the Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation Therapy. Jin Kyu Kang, Mi Sook Kim, Chul Won Choi et al. J Korean Soc Ther Radiol Oncol. 2009;27(3):111-119

방사선비상진료 개론서, 방사성물질의 내부오염 치료지침서 외 다수

2. 공동저자

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines. SH Bae, JK Kang et al. Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):337-351.

Evaluation of Clinical Risk according to Multi-Leaf Collimator Positioning Error in Spinal Radiosurgery. Dong-Jin Kang, Jin-Kyu Kang et al. J. Radiol. Sci. Technol. 2023 vol.46, no.6, pp.527 ? 533

Clinical Risk Evaluation Using Dose Verification Program of Brachytherapy for Cervical Cancer. Dong-Jin Kang, Jin-Kyu Kang et al.J. Radiol. Sci. Technol. 2022, vol.45, no.6, pp. 553-560

Evaluation of setup accuracy for prone breast radiotherapy with a three-dimensional surface imaging system. YM Moon, JK Kang et al.J. Korean Phys. Soc. 2022. 81(11):1182-1186

Development and evaluation of a monoxide-based flexible skin dosimeter for radiotherapy at photon energies. SW Yang, JK Kang et al. JINST. 2021 Jul;16:07056

Evaluation of the Attenuation Rate for Clinical Application of a Flexible Skin Dosimeter in Radiotherapy. Han MJ et al. J.Korean Phys.Soc. 2020 Dec;77(11):1044-1048

Which Is Better for Liver SBRT: Dosimetric Comparison Between DCAT and VMAT for Liver Tumors. Moon YM et al. Front Oncol. 2020 Jul;29:10:1170

Health effects and consultations about radon exposure. Seo SW, Kang JK, Lee DN, Jin YW. J Korean Med Assoc(대한의사협회지). 2019 Jul;62(7):376-382

Internal Dose Assessment after 131I-Iodide Misadministration in a Patient With Incompletely Blocked Thyroid Uptake: Personalized Internal Dose Assessment by Estimating Individual-Specific Biokinetics. Kwon TE et al. Health Phys. 2019 Jun;116(6):760-770

Health effects of exposure to radon: implications of the radon bed mattress incident. Seo S, Ha WH, Kang JK, Lee D, Park S, Kwon TE, Jin YW. Epidemiol Health. 2019 Feb, Epub 

Feasibility of split-course stereotactic ablative radiotherapy for oligometastases. Paik EK, Kim MS, Kang JK et al. Jpn J Clin Oncol. 2018 Jun 1;48(6):548-554

The Clinical Utilization of Radiation Therapy in Korea between 2011 and 2015. Seo YS, Kim MS, Kang JK et al. Cancer Res Treat. 2018 Apr;50(2):345-355

Rebamipide ameliorates radiation-induced intestinal injury in a mouse model. Shim S, Jang HS, Kang JK et al. Toxicol Appl Pharmacol. 2017 Aug 15;329:40-47

Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea. Jang WI, Kang JK et al. Oncotarget. 2017 Feb 7;8(6):9587-9596

High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma. Jang WI, Kim MS, Kang JK et al. Radiat Oncol. 2013 Oct 27;8:250

Curative radiotherapy using different radiation techniques for isolated lung metastasis from colorectal cancer. Lee S, Kim DY, Kang JK et al. Tumori. 2013 Jan-Feb;99(1):68-75

Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies. Bae SH, Kim MS, Cho CK, Kang JK et al. Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e469-74

High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases. Bae SH, Kim MS, Kang JK et al. J Surg Oncol. 2012 Aug 1;106(2):138-43

Nomogram prediction of overall survival after curative irradiation for uterine cervical cancer. Seo YS, Kang JK et al. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):782-787

Three-fraction stereotactic body radiation therapy for isolated liver recurrence from colorectal cancer. Kim MS, Kang JK et al. Tumori. 2009;95(4):449-454

Stereotactic Body Radiotherapy for Isolated Para-aortic Lymph Node Recurrence after Curative Resection in Gastric Cancer. Kim MS et al. J Korean Med Sci. 2009;24(3):488-492